Advanced search
Publication Cover
Gynecological Endocrinology Volume 34, 2018 - Issue 11
Submit an article Journal homepage
571
Views
3
CrossRef citations to date
0
Altmetric
Dienogest in Korean women with endometriosis

Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis

Seon Hwa JeongDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
,
Dayong LeeDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; ;Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Seul Ki KimDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; ;Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected] [email protected]
&
Byung Chul JeeDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; ;Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
Pages 970-974 | Received 01 Jan 2018, Accepted 16 Apr 2018, Published online: 07 May 2018

References

  • Foster RH, Wilde MI. Dienogest. Drugs. 1998;56:825–833.
  • Klipping C, Duijkers I, Faustmann TA, et al. Pharmacodynamic study of four oral dosages of dienogest. Fertil Steril. 2010;94:S181.
  • Strowitzki T, Faustmann T, Gerlinger C, et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2010;151:193–198.
  • Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 2012;285:167–173.
  • Momoeda M, Harada T, Terakawa N, et al. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res. 2009;35:1069–1076.
  • Park SY, Kim SH, Chae HD, et al. Efficacy and safety of dienogest in patients with endometriosis: a single-center observational study over 12 months. Clin Exp Reprod Med. 2016;43:215–220.
  • Kim SA, Um MJ, Kim HK, et al. Study of dienogest for dysmenorrhea and pelvic pain associated with endometriosis. Obstet Gynecol Sci. 2016;59:506–511.
  • Practice Committee of American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;90:260–269.
  • Mahmood TA, Templeton AA, Thomson L, et al. Menstrual symptoms in women with pelvic endometriosis. Br J Obstet Gynaecol. 1991;98:558–563.
  • Laganà AS, La Rosa VL, Rapisarda AMC, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. IJWH. 2017;9:323–330.
  • Caruso S, Iraci M, Cianci S, et al. Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest. J Endocrinol Invest. 2015;38:1211–1218.
  • Caruso S, Iraci M, Cianci S, et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest. 2016;39:923–931.
  • Laganà AS, Vitale SG, Granese R, et al. Clinical dynamics of dienogest for the treatment of endometriosis: from bench to bedside. Expert Opin Drug Metab Toxicol. 2017;13:593–595.
  • Strowitzki T, Faustmann T, Gerlinger C, et al. Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Womens Health. 2015;7:393–401.
  • Köhler G, Faustmann TA, Gerlinger C, et al. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. Int J Gynaecol Obstet. 2010;108:21–25.
  • Sasagawa S, Shimizu Y, Kami H, et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids. 2008;73:222–231.
  • Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25:633–641.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.